Chronic non-cancer pain in primary care: an Italian cross-sectional study

Chronic non-cancer pain is a complex health condition that affects more than a quarter of the Italian population who mainly refers to general practitioners and primary care for their treatment. There are little information on the epidemiological and clinical characteristics and types of treatments for these patients who suffer from chronic pain. The aim of the study was to provide epidemiological and clinical information about patients with chronic non-cancer pain who refers to GPs for their treatment. An observational, multicentre, cross-sectional study was carried out using retrospectively reviewed clinical records from 29 GPs. Some pharmacoeconomic aspects were also investigated. A total of 1,007 patients who had chronic pain were selected for the study. Chronic pain was more common in women than in men (ratio 2.7 : 1) (P = 0.002). With regard to incomes, the women earned less than the men (P = 0.017). The chronic pain was musculoskeletal (73.4%), mixed (21.4%), neuropathic (4.9%) and visceral (0.3%). More women than men had pain in two or more sites, and 33.5% of the patients reported more than one diagnosis that related to chronic pain. The general practitioners had prescribed nonsteroidal anti-inflammatory drugs for 71.8% of the cases, opioids for 16.9%, adjuvants for 9.0% and acetaminophen for 2.4%, and about pharmacoeconomic aspects, the total cost for the sample was € 111,331.42. Primary care is the essential frontline for patients who suffer from non-cancer pain. An interdisciplinary assessment and approach should start in primary care delivery to maximize the clinical outcomes.

Primary care; Epidemiology; General Practitioner; Chronic Pain; Pain Management; Italy; General Population

[1] Institute of Medicine. Committee on Advancing Pain Research Care and Education. The National Academies collection: reports funded by national institutes of health. relieving pain in America: a blueprint for transforming prevention, care, education, and research. National Academies Press. 2011.

[2] Gerbershagen HU, Lindena G, Korb J, Kramer S. Health-related quality of life in patients with chronic pain. Schmerz. 2002; 16: 271-284.

[3] Dysvik E, Lindstrøm TC, Eikeland OJ, Natvig GK. Health-related quality of life and pain beliefs among people suffering from chronic pain. Pain Management Nursing. 2004; 5: 66-74.

[4] Paterniani A, Sperati F, Esposito G, Cognetti G, Pulimeno AML, Rocco G, et al. Quality of life and disability of chronic non-cancer pain in adults patients attending pain clinics: A prospective, multicenter, observational study. Applied Nursing Research. 2020; 14: 151332.

[5] Von Korff M, Lin EH, Fenton JJ, Saunders K. Frequency and priority of pain patients’ health care use. Clinical Journal of Pain. 2007; 23: 400-408.

[6] Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J. Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. Journal of Pain and Palliative Care Pharmacotherapy. 2012; 26: 310-325.

[7] Lynch ME, Schopflocher D, Taenzer P, Sinclair C. Research funding for pain in Canada. Pain Res Manag. 2009; 14: 113-115.

[8] Angeles RN, Guenter D, McCarthy L, Bauer M, Wolfson M, Chacon M, et al. Group interprofessional chronic pain management in the primary care setting: a pilot study of feasibility and effectiveness in a family health team in Ontario. Pain Research and Management. 2013; 18: 237-242.

[9] Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. Chronic painas a symptom or a disease: the IASP Classification of chronic pain for the International Classification of Diseases (ICD-11). Pain. 2019; 160: 19-27.

[10] Andrew R, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice. 2014; 14: 79-94.

[11] Del Giorno R, Frumento P, Varrassi G, Paladini A, Coaccioli S. Assessment of chronic pain and access to pain therapy: a cross-sectional population-based study. Journal of Pain Research. 2017; 10: 2577-2584.

[12] Azevedo LF, Costa-Pereira A, Mendonça L, Dias CC, Castro-Lopes JM. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. Journal of Pain. 2012; 13: 773-783.

[13] Kurita GP, Sjøgren P, Juel K, Højsted J, Ekholm O. The burden of chronic pain: a cross-sectional survey focussing on diseases, immigration, and opioid use. Pain. 2012; 153: 2332-2338.

[14] Flüß E, Bond CM, Jones GT, Macfarlane GJ. The re-evaluation of the measurement of pain in population-based epidemiological studies: The SHAMA study. Brazilian Journal of Pain. 2015; 9: 134-41.

[15] Patel KV, Guralnik JM, Dansie EJ, Turk DC. Prevalence and impact of pain among older adults in the united states: findings from the 2011 national health and aging trends study. Pain. 2013; 154: 2649-57.

[16] Raftery MN, Sarma K, Murphy AW, De la Harpe D, Normand C, McGuire BE. Chronic pain in the Republic of Ireland-community prevalence, psychosocial profile and predictors of pain-related disability: results from the prevalence, impact and cost of chronic pain (PRIME) study, part 1. Pain. 2011; 152: 1096-103.

[17] Molton IR, Terrill AL. Overview of persistent pain in older adults. American Psychologist. 2014; 69: 197-207.

[18] Mogil JS. Sex differences in pain and pain inhibition: multiple expla-nations of a controversial phenomenon. Nature Reviews Neuroscience. 2012; 13: 859-866.

[19] Latina R, De Marinis MG, Giordano F, Osborn JF, Giannarelli D, Di Biagio E, et al. Epidemiology of chronic pain in the Latium region, Italy: A cross-sectional study on the clinical characteristics of patients attending pain clinics. Pain Management Nursing. 2019; 20: 373-381.

[20] Langley PC, Ruiz-Iban MA, Molina JT, De Andres J, Castellón JR. The prevalence, correlates and treatment of pain in Spain. Journal of Medical Economics. 2011; 14: 367-380.

[21] Andersson HIEG, Leden I, Schersten B. Impact of chronic pain on health care seeking, self care, and medication. Results from a population-based Swedish study. Journal of Epidemiology and Community Health. 1999; 53: 503-509.

[22] Mäntyselkä PT, Turunen JH, Ahonen RS, Kumpusalo EA. Chronic pain and poor self-rated health. Journal of the American Medical Association. 2003; 290: 2435-2442.

[23] Smith BH, Hardman JD, Stein A, Colvin L. Managing chronic pain in the non-specialist setting: a new SIGN guideline. British Journal of General Practice. 2014; 64: e462-e4.

[24] Dobscha SK, Corson K, Perrin NA, Hanson GC, Leibowitz RQ, Doak MN, et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. Journal of the American Medical Association. 2009; 301: 1242-1252.

[25] D’Angelo D, Chiara M, Vellone E, Alvaro R, Casale G, Stefania L, et al. Transitions between care settings after enrolment in a palliative care service in Italy: a retrospective analysis. International Journal of Palliative Nursing. 2013; 19: 110-115.

[26] Koleva D, Krulichova I, Bertolini G, Caimi V, Garattini L. Pain in primary care: an Italian survey. European Journal of Public Health. 2005; 15: 475-9.

[27] Leuter C, Piroli A, Paladini A, Tudini M, Varrassi G. Care strategies and therapeutic pathways for chronic pain patients in Abruzzo Region, Italy. Annali di Igiene. 2017; 29: 63-72.

[28] Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. British Medical Journal. 2012; 345: e6341.

[29] Pannek J, Pannek-Rademacher S, Wöllner J. Use of complementary and alternative medicine in persons with spinal cord injury in Switzerland: a survey study. Spinal Cord. 2015; 53: 569-72.

[30] Smith BH, Hopton JL, Chambers WA. Chronic pain in primary care. Family Practice. 1999; 16: 475-482.

[31] Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain. 2008; 9: 105-121.

[32] Dubois MY, Follett KA. Pain medicine: the case for an independent medical specialty and training programs. Academic Medicine. 2014; 89: 863-868.

[33] Damico V, Murano L, Cazzaniga F, Dal Molin A. Pain prevalence, severity, assessment and management in hospitalized adult patients: a result of a multicenter cross-sectional study. Annali dell’Istituto Superiore di Sanita. 2018; 54: 194-200.

[34] Corsi N, Roberto A, Cortesi L, Nobili A, Mannucci PM, Corli O, et al. Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards. European Journal of Internal Medicine. 2018; 55: 35-39.

[35] Latina R, De Marinis MG, Baglìo G, Cattaruzza MS, Notaro P, Guzzetti V, et al. Features and organization of pain centers in the Lazio Region, Italy, in 2011. Annali di Igiene. 2014; 26: 367-379.

[36] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Van-denbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine. 2007; 147: 573-577.

[37] International Association for the Study of Pain (IASP). Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. IASP Press. 1994.

[38] Cabrera-León A, Cantero-Braojos MÁ, Garcia-Fernandez L, Guerra de Hoyos JA. Living with disabling chronic pain: results from a face-to-face cross-sectional population-based study. BMJ Open. 2018; 8: e020913.

[39] Pieretti S, Di Giannuario A, Di Giovannandrea R, et al. Gender differences in pain and its relief. Annali dell’Istituto Superiore di Sanita. 2016; 52: 184-189.

[40] Mansfield KE, Sim J, Jordan JL, Marzoli F, Piccaro G, Minosi P, et al. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016; 157: 55-64.

[41] Kyranou M, Puntillo K. The transition from acute to chronic pain: might intensive care unit patients be at risk? Annals of Intensive Care. 2012; 2: 36.

[42] Newman AK, Kapoor S, Thorn BE. Health care utilization for chronic pain in low-income settings. Pain Medicine. 2018; 19: 2387-2397.

[43] Day MA, Thorn BE. The relationship of demographic and psychosocial variables to pain-related outcomes in a rural chronic pain population. Pain. 2010; 151: 467-74.

[44] Grimby-Ekman A, Gerdle B, Björk J, Larsson B. Comorbidities, intensity, frequency and duration of pain, daily functioning and health care seeking in local, regional, and widespread pain-a descriptive population-based survey (SwePain). BMC Musculoskeletal Disorders. 2015; 16: 165.

[45] Hemp P. Presenteeism: at work-but out of it. Harvard Business Review. 2004; 82: 49-58.

[46] Quintana R, Silvestre AM, Goñi M, García V, Mathern N, Jorfen M, et al. Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina. Clinical Rheumatology. 2016; 35: 5-14.

[47] Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC. et al. Increasing use of opioids from 2004 to 2007-pharmacoepidemiological data from a complete national prescription database in Norway. European Journal of Pain. 2010; 14: 289-294.

[48] National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: pharmacological management in non-specialist settings. Clinical guideline [CG173]. 2013. Available at: https://www.nice. org.uk/guidance/cg173/chapter/1-Recommendations.

[49] O’Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009; 27: 95-112.

[50] Iacorossi L, Gambalunga F, Fabi A, Giannarelli D, Facchinetti G, Piredda M, et al. Adherence to hormone therapy in women with breast cancer: a quantitative study. Professioni Infermieristiche. 2016; 69: 113-121.